.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Management of Dry Eye Disease

Dr Laura Periman, MD discusses biopsychosocial and economic impacts, as well as innovative treatment opportunities for patients with dry eye disease.

EP. 1: Pathology and Prevalence of Dry Eye Disease

June 7th 2022

Dr Laura Periman, MD illustrates the current risk factors and prevalence regarding patients with dry eye disease.

EP. 2: Impact of Dry Eye Disease on Quality of Life

June 14th 2022

Quality-of-life concerns, including biopsychosocial impacts caused by dry eye disease, are explored by Dr Periman.

EP. 3: Identifying Drivers of Economic Burden Associated With Dry Eye Disease

June 21st 2022

Dr Periman addresses cost-related concerns associated with treating dry eye disease.

EP. 4: Exploring Non-Pharmacologic Treatment Options for Patients With Dry Eye Disease

June 28th 2022

Various treatments for dry eye disease are navigated with regard to both payer and provider considerations.

EP. 5: Navigating Breakthrough Pharmacologic Options for Treating Dry Eye Disease

July 5th 2022

Dr Laura Periman introduces current and upcoming pharmacological treatment options, including nasal varenicline, for patients with dry eye disease.

EP. 6: Determining Unmet Needs and Evolutionary Opportunities In Dry Eye Disease Treatment

July 12th 2022

Dr Periman provides final thoughts exploring unmet clinical needs as well as forthcoming innovative opportunities in dry eye disease treatment.